Agilis Biotherapeutics Appoints Dr. Arthur Tzianabos To The Scientific Advisory Board

Agilis Biotherapeutics Appoints Dr. Arthur Tzianabos To The Scientific Advisory Board

Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing best-in-class DNA-based therapeutics for rare genetic diseases, announced today that Arthur Tzianabos, Ph.D., has joined its Scientific Advisory Board. Dr. Tzianabos brings more than 20 years of experience in drug discovery and development of therapeutics in industry and academia. Dr. Tzianabos is currently Chief Scientific Officer of OvaScience, Inc., a global life sciences company developing new fertility treatments.